Given the numerous opportunities and the wide knowledge gaps in pediatric heart failure,
an international group of pediatric heart failure experts with diverse backgrounds were …

Background and purpose Previous studies demonstrated that elevated brain natriuretic
peptide (BNP) level is associated with adverse clinical outcomes of acute cerebral infarction …

Background: Noise from medical institutions such as hospitals usually exceeds the level
recommended by the World Health Organization. This study aimed to explore the application …

Despite tremendous breakthroughs in drug-based and device-based therapy, heart failure
continues to be a serious and growing public health issue linked with substantial disability …

Беспрецедентные достижения последних десятилетий в области клинической
фармакологии, кардиохирургии и имплантационной аритмологии значительно …

Background Quadruple therapy (renin angiotensin system inhibitors, beta-blockers,
mineralocorticoid receptor antagonists and sodium/glucose cotransporter type 2 inhibitors …

Unprecedented advances of recent decades in clinical pharmacology, cardiac surgery,
arrhythmology, and cardiac pacing have significantly improved the prognosis in patients with …

Amyloidosis is a rare and varied group of diseases defined by the misfolding, aggregation,
and deposition of highly structured fibrils made of low molecular weight protein subunits …

Introduction Sacubitril/valsartan is the first-in-class angiotensin-receptor neprilysin inhibitor
approved in 2015 for the treatment of heart failure with reduced ejection fraction (HFrEF). On …

Sažetak Cilj istraživanja: Utvrditi najčešće propisivane lijekove u otpusnoj terapiji bolesnika
s kroničnim zatajivanjem srca hospitaliziranih u KBC-u Split prošle godine te prati li …